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A B S T R A C T
Background
Tinnitus is described as the perception of sound or noise in the absence of real acoustic stimulation. In the current absence of a cure
for tinnitus, clinical management typically focuses on reducing the effects of co-morbid symptoms such as distress or hearing loss.
Hearing loss is commonly co-morbid with tinnitus and so logic implies that amplification of external sounds by hearing aids will reduce
perception of the tinnitus sound and the distress associated with it.
Objectives
To assess the effects of hearing aids specifically in terms of tinnitus benefit in patients with tinnitus and co-existing hearing loss.
Search methods
We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register; the Cochrane Central Register of Controlled Trials
(CENTRAL); PubMed; EMBASE; CINAHL; Web of Science; Cambridge Scientific Abstracts; ICTRP and additional sources for
published and unpublished trials. The date of the search was 19 August 2013.
Selection criteria
Randomised controlled trials and non-randomised controlled trials recruiting adults with subjective tinnitus and some degree of hearing
loss, where the intervention involves amplification with hearing aids and this is compared to interventions involving other medical
devices, other forms of standard or complementary therapy, or combinations of therapies, no intervention or placebo interventions.
Data collection and analysis
Three authors independently screened all selected abstracts. Two authors independently extracted data and assessed those potentially
suitable studies for risk of bias. For studies meeting the inclusion criteria, we used the mean difference (MD) to compare hearing aids
with other interventions and controls.
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Main results
One randomised controlled trial (91 participants) was included in this review. We judged the trial to have a low risk of bias for method
of randomisation and outcome reporting, and an unclear risk of bias for other criteria. No non-randomised controlled trials meeting
our inclusion criteria were identified. The included study measured change in tinnitus severity (primary measure of interest) using
a tinnitus questionnaire measure, and change in tinnitus loudness (secondary measure of interest) on a visual analogue scale. Other
secondary outcome measures of interest, namely change in the psychoacoustic characteristics of tinnitus, change in self reported anxiety,
depression and quality of life, and change in neurophysiological measures, were not investigated in this study. The included study
compared hearing aid use to sound generator use. The estimated effect on change in tinnitus loudness or severity as measured by the
Tinnitus Handicap Inventory score was compatible with benefits for both hearing aids or sound generators but no difference was found
between the two alternative treatments (MD -0.90, 95% confidence interval (CI) -7.92 to 6.12) (100-point scale); moderate quality
evidence. No negative or adverse events were reported.
Authors’ conclusions
The current evidence base for hearing aid prescription for tinnitus is limited. To be useful, future studies should make appropriate
use of blinding and be consistent in their use of outcome measures. Whilst hearing aids are sometimes prescribed as part of tinnitus
management, there is currently no evidence to support or refute their use as a more routine intervention for tinnitus.
P L A I N L A N G U A G E S U M M A R Y
Hearing aids for tinnitus in people with hearing loss
Background
Tinnitus describes ’ringing’, ’whooshing’ or ’hissing’ sounds that are heard in the absence of any corresponding external sound. About
10% of people experience tinnitus and for some it has a significant negative impact on their quality of life. Tinnitus is commonly
associated with some form of hearing loss and is possibly the result of hearing loss-related changes in brain activity. It is logical to
think, therefore, that providing people who have hearing loss and tinnitus with a hearing aid will not only improve their ability to hear
sound but will also reduce their tinnitus symptoms. Hearing aids increase the volume at which people hear external sounds so this
may help mask or cover up the tinnitus sound. They also improve communication, which may reduce the symptoms often associated
with tinnitus such as stress or anxiety. Hearing aids may also improve tinnitus symptoms by reducing or reversing abnormal types of
nerve cell activity that are thought to be related to tinnitus. The purpose of this review is to evaluate the evidence from high-quality
clinical trials that try to work out the effects hearing aids have on people’s tinnitus. We particularly wanted to look at how bothersome
their tinnitus is, how depressed or anxious tinnitus patients are and whether hearing aid use has an effect on patterns of brain activity
thought to be associated with tinnitus.
Study characteristics
Our search identified just one randomised controlled trial which evaluated 91 participants who had tinnitus for at least six months
and some degree of hearing loss. It compared those receiving hearing aids to those receiving sound generators. The average age of the
patients was 38 and there were 40 women and 51 men. The study took place in two centres in Italy and the USA.
Key results
The result from the single study we reviewed was not definitive and was compatible with only small differences between the effect of
hearing aids and sound generators. We also found another relevant study which has not yet been completed. We believe further high-
quality trials are needed.
Quality of the evidence
The quality of this evidence is moderate to low. This review is up to date to August 2013.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Hearing aids compared to sound generator for patients with tinnitus and co-existing hearing loss
Patient or population: patients with tinnitus and co-existing hearing loss
Settings: audiology
Intervention: hearing aids
Comparison: sound generators
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Sound generators Hearing aids
Tinnitus severity or
handicap
Measured by Tinni-
tus Handicap Inventory
(scale range from 0 to
100)
Follow-up: mean 12
months
The mean change in the
control group was -29.2
points
The mean change in the
hearing aids group was 0.
9 higher
(6.12 lower to 7.92
higher)
91
(1)
⊕⊕⊕©
moderate1
In both groups the THI
score reduced from a
baseline of around 58. A
higher (i.e. larger) reduc-
tion means a bigger im-
provement
A change of 20 points
on the Tinnitus Handicap
Inventory is considered
clinically significant
Tinnitus sound quality
(loudness)
Measured with a visual
analogue scale (scale
range from 0 to 10)
The mean change in the
control group was -3.4
points
The mean change in the
hearing aids group was 0
higher
(0.64 lower to 0.64
higher)
91
(1)
⊕⊕©©
low1
Psychoacoustic mea-
sures could have been
used to measure tinnitus
sound quality. However,
this was not reported and
only VAS measures were
available2. A higher score
means ’worse’.
Generalised anxiety - not
measured
- - - - - -
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Generalised depression
- not measured
- - - - - -
Quality of life - not mea-
sured
- - - - - -
Coping (style) - not mea-
sured
- - - - - -
Neurophysiology
changes - not measured
- - - - - -
Adverse events of hear-
ing aid fitting and use -
not measured
- - - - - -
CI: confidence interval; THI: Tinnitus Handicap Inventory; VAS: visual analogue scale
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1A number of items are unclear or under-reported. We were unable to get clarification about the conduct of the power calculation or the
use of blinding. If there was no blinding, this is an important risk for subjective patient-reported outcomes. The tinnitus questionnaire
used is not sensitive to treatment-related change.
2A VAS is not a considered a validated measure of loudness.
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B A C K G R O U N D
Tinnitus is defined as the perception of sound in the absence of
an external source (Jastreboff 2004). It is typically described by
those who experience it as a ringing, hissing, buzzing or whooshing
sound and is thought to result from abnormal neural activity at
some point or points in the auditory pathway which is erroneously
interpreted by the brain as sound. Tinnitus can be either objective
or subjective. Objective tinnitus refers to the perception of sound
that can also be heard by the examiner and is usually due to blood
flow or muscle movement (Eggermont 2010). Most commonly,
however, tinnitus is subjective; the sound is only heard by the
person experiencing it and no source of the sound is identified
(Jastreboff 1988).
Subjective tinnitus affects 10% of the general population, increas-
ing to as many as 30% of adults over the age of 50 years (Davis
2000; Møller 2000). It can be experienced acutely, recovering
spontaneously within minutes to weeks, but is considered chronic
and unlikely to resolve spontaneously when experienced for three
months or more (Hahn 2008; Hall 2011; Rief 2005).
In England alone there are an estimated ¾ million GP con-
sultations every year where the primary complaint is tinnitus
(El-Shunnar 2011), equating to a major burden on healthcare ser-
vices. For many people tinnitus is persistent and troublesome, and
has disabling effects such as insomnia, difficulty concentrating,
difficulties in communication and social interaction, and negative
emotional responses such as anxiety and depression (Andersson
2009; Crönlein 2007; Marciano 2003). In approximately 90% of
cases, chronic tinnitus is co-morbid with some degree of hearing
loss which may confound these disabling effects (Fowler 1944;
Sanchez 2002). An important implication of this in clinical re-
search, therefore, is that outcome measures need to distinguish
benefits specific to improved hearing from those specific to tinni-
tus.
Description of the condition
Diagnosis and clinical management of tinnitus
There is no standard procedure for the diagnosis ormanagement of
tinnitus. Practice guidelines and the approaches described in stud-
ies of usual clinical practice typically reflect differences between
the clinical specialisms of the authors or differences in the clinical
specialisms charged with meeting tinnitus patients’ needs (medi-
cal, audiology/hearing therapy, clinical psychology, psychiatry), or
the available resources of a particular country or region (access to
clinicians or devices, for example) (Biesinger 2010; Cima 2012;
Department of Health 2009; Hall 2011; Henry 2008; Hoare
2011a). Common across all these documents, however, is the use
or recommendation of written questionnaires to assess tinnitus
and its impact on patients by measuring severity, quality of life,
depression or anxiety. Psychoacoustic measures of tinnitus (pitch,
loudness, minimum masking level) are also recommended. Al-
though these measures do not correlate well with tinnitus severity
(Hiller 2006) they can prove useful in patient counselling (Henry
2004) or by demonstrating stability of the tinnitus percept over
time (Department of Health 2009).
Clinical management strategies include education and advice, re-
laxation therapy, tinnitus retraining therapy (TRT), cognitive be-
havioural therapy (CBT), sound enrichment using ear-level sound
generators or hearing aids, and drug therapies to manage co-mor-
bid symptoms such as insomnia, anxiety or depression. The effects
of these management options are variable and have few known
risks or adverse effects (Dobie 1999; Hoare 2011; Hobson 2010;
Martinez-Devesa 2010; Phillips 2010).
Pathophysiology
Most people with chronic tinnitus have some degree of hearing
loss (Ratnayake 2009) and the prevalence of tinnitus increases with
greater hearing loss (Han 2009; Martines 2010). The varying the-
ories of tinnitus generation involve changes in either function or
activity of the peripheral (cochlea and auditory nerve) or central
auditory nervous systems (Henry 2005). Theories involving the
peripheral systems include the discordant damage theory which
predicts that the loss of outer hair cell function, where inner hair
cell function is left intact, leads to a release from inhibition of inner
hair cells and aberrant activity (typically hyperactivity) in the au-
ditory nerve (Jastreboff 1990). Such aberrant auditory nerve activ-
ity can also have a biochemical basis, resulting from excitotoxicity
or stress-induced enhancement of inner hair cell glutamate release
with upregulation of N-methyl-D-aspartate (NMDA) receptors
(Guitton 2003; Sahley 2001).
In the central auditory system, structures implicated as possible
sites of tinnitus generation include the dorsal cochlear nucleus
(Middleton 2011; Pilati 2012), the inferior colliculus (Dong 2010;
Mulders 2010), and the auditory and non-auditory cortex (dis-
cussed further below). There is a strong rationale that tinnitus
is a direct consequence of maladaptive neuroplastic responses to
hearing loss (Møller 2000;Mühlnickel 1998). This process is trig-
gered by sensory deafferentation and a release from lateral inhi-
bition in the central auditory system allowing irregular sponta-
neous hyperactivity within the central neuronal networks involved
in sound processing (Eggermont 2004; Rauschecker 1999; Seki
2003). As a consequence of this hyperactivity, a further physio-
logical change noted in tinnitus patients is increased spontaneous
synchronous activity occurring at the cortical level, measurable us-
ing electroencephalography (EEG) or magnetoencephalography
(MEG) (Dietrich 2001; Tass 2012; Weisz 2005). Another phys-
iological change thought to be involved in tinnitus generation is
a process of functional reorganisation which amounts to a change
in the response properties of neurons within the primary auditory
cortex to external sounds. This effect is well demonstrated physio-
logically in animal models of hearing loss (Engineer 2011; Noreña
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2005). Evidence in humans, however, is limited to behavioural
evidence of cortical reorganisation after hearing loss, demonstrat-
ing improved frequency discrimination ability at the audiomet-
ric edge (Kluk 2006; McDermott 1998; Moore 2009; Thai-Van
2002; Thai-Van 2003), although Buss 1998 did not find this ef-
fect. For comprehensive reviews of these physiological models, see
Adjamian 2009 and Noreña 2011.
It is also proposed that spontaneous hyperactivity could cause an
increase in sensitivity or ’gain’ at the level of the cortex, whereby
neural sensitivity adapts to the reduced sensory inputs, in effect
stabilising mean firing and neural coding efficiency (Noreña 2011;
Schaette 2006; Schaette 2011). Such adaptive changes would be
achieved at the cost of amplifying ’neural noise’ due to the overall
increase in sensitivity, ultimately resulting in the generation of
tinnitus.
Increasingly, non-auditory areas of the brain, particularly areas as-
sociated with emotional processing, are also implicated in bother-
some tinnitus (Rauschecker 2010; Vanneste 2012). Vanneste 2012
describes tinnitus as “an emergent property of multiple parallel
dynamically changing and partially overlapping sub-networks”,
implicating the involvement of many structures of the brain more
associated withmemory and emotional processing in tinnitus gen-
eration. However, identification of the structural components of
individual neural networks responsible for either tinnitus genera-
tion or tinnitus intrusiveness, which are independent of those for
hearing loss, remains open to future research (Melcher 2012).
One further complication in understanding the pathophysiology
of tinnitus is that not all people with hearing loss have tinnitus and
not all people with tinnitus have a clinically significant hearing
loss. Other variables, such as the profile of a person’s hearing loss,
may account for differences in their tinnitus report. For example,
König 2006 found that the maximum slope within audiograms
was higher in people with tinnitus than in people with hearing loss
who do not have tinnitus, despite the ’non-tinnitus’ group having
the greater mean hearing loss. This suggests that a contrast in
sensory inputs between regions of normal and elevated threshold
may be more likely to result in tinnitus.
Description of the intervention
The standard function of a digital hearing aid is to amplify and
modulate sound, primarily for the purpose of making sound more
accessible and aiding communication. Using hearing aids in tin-
nitus management has been proposed as a useful strategy since
the 1940s (Saltzman 1947), although the benefit reportedly varies
and there is no clear consensus on when a person would or would
not benefit from amplification (Henry 2005; Hoare 2012). Beck
2011 proposes that hearing aid fittings for people with very mild
up to moderate sensorineural hearing loss (who might not ordi-
narily look for or be prescribed a hearing aid) can lead to signif-
icant improvements in tinnitus. Currently, hearing aids, supple-
mented with education and advice, form a common intervention
for someone who has tinnitus and an aidable hearing loss (Hoare
2012). This combination of hearing aid provision with education
and advice might be considered a complex intervention with in-
terdependent components (Shepperd 2009).
There are many options for hearing aid fitting which complicate
their use in tinnitus. For example, Del Bo 2007 suggests that
the best clinical result for someone with tinnitus requires bilateral
rather than monolateral amplification. Trotter 2008, however, in
describing a 25-year experience of hearing aids in tinnitus therapy,
found no difference in tinnitus improvement between unilaterally
and bilaterally aided patients. For other aspects of hearing aid fit-
ting there appears to be greater consensus; for example, the value of
using open-fitting aids, which allow natural environmental sound
to enter the ear, as well as amplifying those sounds, thus improving
perceived sound quality (Del Bo 2007; Forti 2010).
The effect of amplification on tinnitus may be in part determined
by the degree to which different frequencies are amplified by the
hearing aid. Moffat 2009 examined the effect of amplification on
objectively measured tinnitus pitch characteristics. The authors
compared the effects of two very distinct amplification gain pro-
files in patients with a dominant tinnitus pitch that was typically
above or equal to 4 kHz. A ’standard amplification’ group received
gain that was limited to the low and medium ends of the au-
dible spectrum (with minimal amplification above 4 kHz). One
month after fitting there was a significant reduction in the contri-
butions of low frequencies (250, 500 and 750 Hz) to the tinnitus
pitch percept. A ’high-bandwidth amplification’ group received
gain that provided enhanced audibility at 4 to 6 kHz. One month
after fitting there was no change in tinnitus pitch characteristics.
In contrast, Schaette 2010 examined the effect of amplification
on self reported benefits. Their study addressed the influence of
dominant tinnitus pitch on outcome in patients receiving ’stan-
dard amplification’. Pilot results indicated a significant reduction
in tinnitus severity and loudness in those participants whose dom-
inant tinnitus pitch fell within the stimulated frequency range of
the device (i.e. less than 6 kHz), but not in those whose dominant
tinnitus pitch was 6 kHz or more. Since neither study measured
both tinnitus pitch characteristics and self reported benefits, the
link between these two outcomes requires further investigation.
Finally, hearing aid prescription might also be combined with
other forms of therapy, such as formal counselling, albeit with
mixed evidence for the effects of such combinations of therapies
(Hiller 2005; Hobson 2010; Phillips 2010; Searchfield 2010).
How the intervention might work
Hearing aids may be beneficial for people with tinnitus in a num-
ber of ways. The amplification of external sounds may reverse or
reduce the drive responsible for ’pathological’ changes in the cen-
tral auditory system associated with hearing loss, such as increased
gain or auditory cortex reorganisation, possibly by strengthening
lateral inhibitory connections. Increased neuronal activity that re-
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sults from amplified sounds may reduce the contrast between tin-
nitus activity and background activity thus reducing audibility and
the awareness of tinnitus. Alternatively, amplification may simply
refocus attention on alternative auditory stimuli that are incom-
patible and unrelated to the tinnitus sound. The primary purpose
of fitting a hearing aid is to reduce hearing difficulties and improve
communication (Dillon 2012), which for some people should re-
duce the stress and anxiety that may be associated with their hear-
ing difficulties (Surr 1985). This may lead to changes in self re-
ported measures of tinnitus handicap which contain questions on
tinnitus-related stress or anxiety. Finally, there is likely to be the
potential for a large placebo effect in any study of tinnitus (Dobie
1999) and so it is essential that any investigation of hearing aids
for tinnitus considers the potential impact of this effect.
Why it is important to do this review
This review is important because 1) hearing aids are a recom-
mended intervention if an individual has bothersome tinnitus and
some hearing loss, 2) the evidence base which supports current
clinical practice has not been systematically collated and 3) this is
a rapidly evolving field. Hearing aid technology is ever advancing,
with increasing emphasis on open-fitting aids, greater bandwidths
of amplification (up to 10 kHz), better feedback cancellation tech-
niques and signal processing programs, and the combination of a
hearing aid with a tinnitus masker or sound generator in a single
digital device (Forti 2010; Sweetow 2010). There has never been
a dedicated systematic review on the specific effects of amplifica-
tion on tinnitus. This review is important, therefore, not only as
a synthesis of the data that currently exist on the use of hearing
aids as an intervention in tinnitus management, but as a working
document that can set and forecast important questions on the
topic.
O B J E C T I V E S
To assess the effects of hearing aids specifically in terms of tinnitus
benefit in patients with tinnitus and co-existing hearing loss.
M E T H O D S
Criteria for considering studies for this review
Types of studies
In the protocol for this review we anticipated including both ran-
domised and non-randomised studies. In this review we have clar-
ified this as follows. The ’non-randomised studies’ we planned
to include were those conducted in a very similar manner to
RCTs, but with an inadequate randomisation technique (quasi-
randomised trials) or where allocation was not randomised (non-
randomised controlled trials). Cluster-randomised trials would
also be included. Features of these trials are as defined in Table
13.2a of theCochrane Handbook for Systematic Reviews of Interven-
tions (Handbook 2011).
Specifically, non-randomised controlled trials would only be in-
cluded if:
1. hypotheses, identification of participants, baseline and
outcome measurements are pre-defined, i.e. trials are prospective;
2. the primary design was selected to make a between-group
and not a within-group controlled comparison; and
3. participants were allocated by an action of the researcher
(Handbook 2011).
For inclusion we also required the primary question of the non-
randomised controlled trial to reflect that of the review (Wells
2013) and so inform recommendations for future relevant trials.
Types of participants
Adults (18 years and above) with subjective tinnitus and some
degree of hearing loss.
Types of interventions
Studies were included where patients with tinnitus received a hear-
ing aid (with any standard educational/informational support) and
this was compared to either care involving other medical devices,
other forms of standard or complementary therapy or combina-
tions of therapies, no interventionor placebo interventions.Where
available, we report details of the fitting procedure and type of
hearing aid used.
Types of outcome measures
Primary outcomes
• Tinnitus severity or handicap, measured as a change
between baseline (pre-hearing aid fitting) and follow-up
compared to a control, using a tinnitus questionnaire listed in
Table 1. This list will be updated on an ongoing basis whenever
other questionnaires are validated.
Secondary outcomes
• Generalised anxiety
• Generalised depression
• Quality of life
• Coping (style)
All measured as change (from baseline) using validated question-
naires.
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• Tinnitus sound quality (e.g. dominant pitch, loudness),
measured as changes in psychoacoustic measures
• Neurophysiology changes (e.g. change in neural activity as
measured by functional magnetic resonance imaging (fMRI),
electroencephalography (EEG), magnetoencephalography
(MEG) etc.)
• Adverse effects of hearing aid fitting and use
The use of appropriate outcomes and outcome measures (i.e. how
the outcomes were measured) is particularly important tinnitus
research. Both selective outcome reporting and detection bias are
important issues that we will consider in this review.
Search methods for identification of studies
We conducted systematic searches for randomised controlled trials
and controlled clinical trials. There were no language, publication
year or publication status restrictions. The date of the search was
19 August 2013.
Electronic searches
We searched the following databases from their inception for pub-
lished, unpublished and ongoing trials: the Cochrane Ear, Nose
andThroatDisordersGroupTrials Register; theCochraneCentral
Register of Controlled Trials (CENTRAL, The Cochrane Library
2013, Issue 7); PubMed; EMBASE; CINAHL; AMED; LILACS;
KoreaMed; IndMed; PakMediNet; CAB Abstracts; Web of Sci-
ence; ISRCTN; ClinicalTrials.gov; ICTRP; Google Scholar and
Google. In searches prior to 2013, we also searched BIOSIS
Previews 1926 to 2012.
Wemodelled subject strategies for databases on the search strategy
designed for CENTRAL. Where appropriate, we combined sub-
ject strategies with adaptations of the highly sensitive search strat-
egy designed by The Cochrane Collaboration for identifying ran-
domised controlled trials and controlled clinical trials (as described
in the Cochrane Handbook for Systematic Reviews of Interventions
Version 5.1.0, Box 6.4.b. (Handbook 2011)). Search strategies for
major databases, including CENTRAL, are provided in Appendix
1.
Searching other resources
We supplemented the electronic searches with searches of all the
research studies included in a current scoping review (Shekhawat
2013) and the reference list of the included study.
We searched for conference abstracts using theCochrane Ear,Nose
and Throat Disorders Group Trials Register.
Data collection and analysis
Selection of studies
Three authors (DJH, DH, MAA) independently reviewed all ar-
ticles retrieved to determine their eligibility for inclusion in the
review. We considered multiple articles reporting the same study
together as a single record. Disagreements were discussed between
all three authors until a consensus was reached. We contacted au-
thors of studies where there was insufficient information to eval-
uate eligibility for inclusion.
Data extraction and management
Two authors (MEJ,MS) independently extracted data using a data
extraction form designed specifically for the review, which was
piloted on a subset of articles and revised as appropriate before
formal data extraction began.
Assessment of risk of bias in included studies
Two authors (MS, MEJ) independently assessed the risk of bias of
the included trials, with the following taken into consideration, as
guided by theCochrane Handbook for Systematic Reviews of Inter-
ventions (Handbook 2011):
• sequence generation;
• allocation concealment;
• blinding;
• incomplete outcome data;
• selective outcome reporting; and
• other sources of bias, such as the use of patient-reported
outcome measures with insufficient validity and sensitivity to
detect changes.
For the assessment of RCTs we used the Cochrane ’Risk of bias’
tool in RevMan 5.2 (RevMan 2012), which involves describing
each of these domains as reported in the trial and then assigning
a judgement about the adequacy of each entry: ’low’, ’high’ or
’unclear’ risk of bias.
Measures of treatment effect
If data were available, we planned to analyse dichotomous data as
risk ratios (RR) with 95% confidence intervals (95% CIs).
We analysed outcomes measured using scales as continuous out-
comes. Continuous outcomes are summarised as mean difference
(MD) with 95% CI. We also planned to use standardised mean
difference (SMD), also known as Cohen’s d effect size (ES), par-
ticularly when different scales were used to measure an outcome.
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Unit of analysis issues
We anticipated the following unit of analysis issues in this review:
• the unit of randomisation was at the group level, i.e.
cluster-randomised trials;
• multiple observations were made for the same outcome
(e.g. repeated measurements) at different time points.
If appropriate studies had been identified, we would have used
data extraction and analysis techniques which take into ac-
count the effect of clustering, as recommended in Chapter 16
of the Cochrane Handbook for Systematic Reviews of Interventions
(Handbook 2011). To minimise the issue of repeated measure-
ment of data, we would only incorporate data at the most relevant
time points rather than analysing each time point reported by the
included studies.
Dealing with missing data
In line with the recommendations contained in the Cochrane
Handbook for Systematic Reviews of Interventions (Handbook
2011), where possible we planned to contact the original inves-
tigators to request missing data. In this review some values were
not reported in the text but sufficient information was presented
in the report diagrams and figures. It is clearly stated throughout
the review where estimation was used.
Assessment of heterogeneity
In addition to statistical heterogeneity, we would have considered
the issue of clinical heterogeneity (in terms of patient population,
intervention, comparison and how outcomes were measured) be-
fore we made any decision to pool the data and in the description
of results.
If more than one study was found and included in the meta-anal-
ysis, we would have visually inspected forest plots for the pres-
ence of heterogeneity. We would also have used formal statistical
tests: Cochran’s Q statistic (Chi2 test with K-1 degrees of free-
dom, where K is the number of studies) and the I2 statistic. We
would have considered statistical heterogeneity to be present if the
P value of the Chi2 test was 0.1 or the I2 value was 50% or higher
(Handbook 2011).
Assessment of reporting biases
We planned to investigate potential publication bias and the in-
fluence of individual studies on the overall outcome of this review
using a funnel plot (Egger 1997). However, there were insufficient
studies included to make this analysis meaningful. Other aspects
of reporting bias were assessed as part of the selective (outcome)
reporting ’Risk of bias’ assessment. Our search strategy also in-
cluded key trial registries and any studies completed with unpub-
lished results would have been noted.
Data synthesis
If more than one study had been identified and if combining
studies was appropriate we had planned to use RevMan 5.2 (
RevMan 2012) to perform meta-analysis. With just one included
study, however, we analysed data to support a narrative synthesis
that reports both statistical and clinical significance levels. We
had planned to pool data from randomised controlled trials using
a fixed-effect model, except when heterogeneity was found. We
planned to pool dichotomous data using the RR measure, while
continuous data were to be pooled using the standardised mean
difference (SMD) measure if more than scale or questionnaire
was used to measure the same outcome. We would have given
consideration to the psychometric properties of the questionnaire
with regard to the suitability for pooling.
This review planned to include data from both RCTs and non-
RCTs. However, we planned to analyse these studies separately
according to the recommendations of the Cochrane Non-Ran-
domised Studies Methods Group, to take into account issues re-
lating to confounders and heterogeneity of data (Valentine 2013).
Subgroup analysis and investigation of heterogeneity
Where appropriate the following potential sources of heterogene-
ity are discussed: age, sex, hearing loss (pure-tone average), base-
line tinnitus severity, baseline hearing handicap, baseline level of
anxiety or depression.
Sensitivity analysis
We planned to perform a sensitivity analysis to explore whether
any significant heterogeneity was a result of low trial quality. We
planned to exclude the lowest quality trials if appropriate.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
Our electronic database search on 19 August 2013 identified 360
records. A further three records were identified from a handsearch
of the one study included in this review and a newly published
scoping review (Shekhawat 2013). After the removal of duplicates,
we were left with 330 records. We discarded 115 records and
retrieved 215 abstracts for assessment. Following screening of these
we retrieved 69 full-text papers. From these we discarded 39 as
they did not address the research question (for example, 19 were
9Amplification with hearing aids for patients with tinnitus and co-existing hearing loss (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
tinnitus review articles). From the remaining 30, we discarded a
further 17 as they were not RCT or non-RCT study designs. We
formally excluded 11 RCT or non-RCT studies as they either did
not test a relevant intervention or control, or they did not use a
tinnitus questionnaire as an outcome measure.
Just one completed study met our inclusion criteria (Parazzini
2011). We identified one further ongoing study which could
potentially meet our criteria for inclusion when published (
NCT01857661).
No studies comparing hearing aids to no intervention or to a
placebo intervention were identified.
See Figure 1 for a flow chart showing the search process for the
search. Those RCTs and non-RCTs that we formally excluded are
listed in Characteristics of excluded studies, with details of the
reason for exclusion.
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Figure 1. Process for sifting search results and selecting studies for inclusion.
11Amplification with hearing aids for patients with tinnitus and co-existing hearing loss (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Included studies
We included one study in the review (Parazzini 2011). This study
examined the effects of hearing aid use on tinnitus, compared to
the effects of a sound generator device, and used a questionnaire
to measure tinnitus handicap. It also used a visual analogue scale
(VAS) of tinnitus loudness.
Design
Parazzini 2011was a two-centre, randomised, controlled (parallel),
repeated-measures trial.
Sample size
One hundred and one patients were enrolled, but due to missing
records the final data set included only 91 patients.
Setting
Patients were screened and treated in one of two tinnitus clinics
(Italy or USA).
Participants
Group level data for age, duration of tinnitus and hearing loss were
not provided by Parazzini 2011. The 91 patients included in the
final analysis had a mean age of 38.8 years (SD 18.1) and a mean
tinnitus duration of 69.5 months (SD 89.7). Baseline measures
included an audiological test for hearing loss. Mean hearing loss
was not reported per group but inclusion in the study required
patients to have hearing levels < 25 dB at 2 kHz and > 25 dB at
frequencies higher than 2 kHz. This was taken as the borderline
between two categories: ’no hearing loss’ and ’significant hearing
loss’. According to Jastreboff 2004, patients with this hearing level
can be managed with either hearing aids or sound generators. The
participants in this study therefore had a very particular audiolog-
ical profile. Patients who had previously been prescribed hearing
aids were excluded from participation in the trial.
Group level data for gender and baseline tinnitus severity were
provided by Parazzini 2011 and groups were comparable on both
variables. The groupwho receivedhearing aids included21women
and 28 men, and the group receiving sound generators included
19 and 23 men. The mean Tinnitus Handicap Inventory (THI)
score at baseline was 57 for the hearing aid group and 59 for the
sound generator group.
Interventions
One group were fitted with bilateral open ear hearing aids (n =
49) and one group were fitted with bilateral sound generators (n
= 42). All hearing aid patients were fitted with the ’ResoundAir’
device (GN Resound), programmed according to standard audi-
ological practice. In terms of the type of sound generators, all pa-
tients were fitted with behind-the-ear open fit ’Silent Star’ devices
(Viennatone) which produce a broadband sound. All patients re-
ceived the same educational counselling component of tinnitus
retraining therapy (TRT), with follow-up to optimise the therapy
at three, six and 12 months.
Outcomes
Change in tinnitus symptoms was measured using the Tinnitus
Handicap Inventory (Table 1; Newman 1996). A number of vi-
sual analogue scales were used to rate tinnitus loudness over the
preceding month (rated from 0 = no tinnitus to 10 = ’as loud as
you can imagine’), effect on life, tinnitus annoyance, percentage
of time when patients were annoyed and percentage of time when
patients were aware of their tinnitus. Outcomes were measured at
three, six and 12 months during the tinnitus treatment.
Excluded studies
See: Characteristics of excluded studies for details of the 11 RCTs
and non-RCTs excluded because of the intervention or control
they used (n = 6) or because of the outcome measures they used (n
= 5) (dos Santos Ferrari 2007; Eysel-Gosepath 2004; Forti 2010;
Hazell 1985; Henry 2006; Kießling 1980; Mehlum 1984; Melin
1987; Moffat 2009; Oz 2013; Schaette 2010).
Risk of bias in included studies
Two authors (MS, MEJ) critically reviewed study methodology
and graded the quality of the study according to the stated crite-
ria. We contacted the lead author of the included study on two
occasions to ask for more details of their methodology where risk
of bias was unclear, however we had not received a response at the
time of submission. For a summary of the risk of bias in this study
see Figure 2.
12Amplification with hearing aids for patients with tinnitus and co-existing hearing loss (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 2. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for the included
study.
Allocation
The authors of Parazzini 2011 state that “Randomization was ob-
tained on the basis of a random table”. From this it is unclear
whether investigators were aware of allocation before enrolment,
so we judged selection bias to be unclear.
Blinding
The use of blinding was not reported so the risk of performance
bias is unclear.Outcomemeasurement involved self reported ques-
tionnaires. Whether or not there was blinding of researchers was
not reported, again representing an unclear risk of detection bias.
Incomplete outcome data
We judged Parazzini 2011 to have a low risk of attrition bias. They
excluded participants from both groups after randomisation be-
cause of lost records rather than any systematic exclusion process.
The loss of outcome data in all cases was due to a single reason
and was similar across groups.
Selective reporting
We judged Parazzini 2011 to have a low risk of selective reporting
bias. Although psychoacoustic measures of tinnitus loudness and
pitch were collected at baseline and not repeated at follow-up, the
most clinically meaningful measures were repeated at follow-up.
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Other potential sources of bias
Parazzini 2011 conducted a power analysis but the authors do not
report the basis for this. They included 91 participants in the study
although only 80 were required for adequate statistical power. No
justification was given. We judged the study to be at low risk for
other potential sources of bias.
Effects of interventions
See: Summary of findings for the main comparison Hearing
aids compared to sound generator for patients with tinnitus and
co-existing hearing loss
Hearing aids versus sound generator device
The included randomised controlled trial (RCT) (Parazzini 2011)
compares hearing aids for tinnitus management versus a sound
generator device, hence this is the only comparison which can be
analysed in this review.
Primary outcome measure
Tinnitus severity or handicap, measured as a change between
baseline (pre-hearing aid fitting) and follow-up
Parazzini 2011 reported no statistically significant difference in the
change in tinnitus handicap between groups. Tinnitus Handicap
Inventory (THI) scores were assessed at 12 months. We estimated
mean values from the data plots (in Figure 1 of their paper). For
patients who were fitted with a hearing aid, the THI score re-
duced from ~58.9 to ~28.8 (the questionnaire range is 0 to 100),
whereas the group who received sound generators reported a re-
duction from ~56.8 to ~27.6. Parazzini 2011 performed a two-
way ANOVA showing that the reduction in THI was statistically
significant overall (P < 0.001), but there was no significant dif-
ference between groups (mean difference (MD) -0.90, 95% con-
fidence interval (CI) -7.92 to 6.12; standardised mean difference
(SMD) 0.05, 95%CI -0.36 to 0.46) (Analysis 1.1). The reduction
in THI score seen in both groups was clinically significant (i.e.
more than 20 points, Newman 1996).
Secondary outcome measures
Generalised anxiety
Parazzini 2011 did not include any outcome measures of gener-
alised anxiety.
Generalised depression
Parazzini 2011 did not include any outcome measures of gener-
alised depression.
Quality of life
Parazzini 2011 did not include any outcome measures of gener-
alised quality of life.
Coping (style)
Parazzini 2011 did not include any outcome measures of coping.
Tinnitus sound quality (e.g. dominant pitch, loudness),
measured as changes in psychoacoustic measures
Parazzini 2011 did not perform psychoacoustic measurement of
tinnitus.
Both groups reported a reduction in tinnitus loudness using a
visual analogue scale (VAS) score at 12 months follow-up, but this
did not differ significantly between groups (SMD 0, 95% CI -
0.64 to 0.64) (Analysis 1.2).
Neurophysiology changes
Parazzini 2011 did not measure neurophysiology changes.
Adverse effects of hearing aid fitting and use
Neither a plan to measure adverse effects nor the occurrence of
adverse effects was reported by Parazzini 2011.
D I S C U S S I O N
Summary of main results
The objective of this review was to evaluate the effects of amplifi-
cation with hearing aids in patients with tinnitus and a co-existing
hearing loss.
We found no evidence relating to the comparison of hearing aids
with placebo or no intervention.
For the comparison of hearing aids versus sound generators, only
one small RCT met the inclusion criteria. The included RCT
found no difference between the effect of hearing aids and sound
generators on the change in self reported tinnitus handicap or VAS
scores of tinnitus loudness. The use of both was associated with a
clinically significant reduction in tinnitus handicap. In summary,
hearing aids were not better or worse than sound generators. No
evidence was found for the other outcomes of interest in this re-
view. See Summary of findings for the main comparison.
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Overall completeness and applicability of
evidence
This review found evidence from one small RCT for two out-
comes measured using self reported measures, i.e. change in tin-
nitus questionnaire scores for tinnitus severity or VAS for tinnitus
loudness, in a patient population who might receive the interven-
tion in practice.
The study was conducted on a clinical population, making the
findings on the face of it externally valid.However, the participants
had a very specific audiological profile, representing a group with
a specific type and degree of hearing loss. It is not clear whether
or not the findings are equally applicable to patients with more
severe hearing loss.
We found no evidence comparing hearing aids with either placebo
or no intervention.
Quality of the evidence
We consider the quality of evidence for the main outcome to be
moderate, i.e. further research is likely to have an important impact
on our confidence in the estimate of effect and may change the
estimate. There are some important limitations in the design and
conduct of the study. The report of the included study (Parazzini
2011) did not provide any information about blinding and there-
fore this is a concern as subjective patient-reported outcomes were
used. In addition, the choice of outcomemeasure (TinnitusHand-
icap Inventory) used tomeasure tinnitus severity was not originally
developed as an outcome measure. It uses a scoring system that
is not sensitive to small treatment-related changes (Meikle 2008).
Key properties for any outcome instrument are content validity,
reproducibility and responsiveness (Terwee 2007).
Psychoacoustic measures of tinnitus pitch or loudness were col-
lected at baseline butwere not used as outcomemeasures (Parazzini
2011). It is unclear whether or not this results in selective report-
ing bias. However, the study reported tinnitus loudness based on
a VAS scale.
As we found only one RCT, the overall number of participants
available for data analysis was relatively small. Although the au-
thors of the included study had conducted a power calculation,
they provided little detail about this and recruited beyond it (80
participants required for power but 101 participants recruited in
the first instance, and 91 participants reported). The rationale be-
hind this is not clear. As the confidence intervals did not exceed
minimum clinically important differences, we made no further
downgrading for imprecision.
Potential biases in the review process
Our searches of electronic databases and journal websites were
comprehensive. We also searched the reference list of the included
study and a current scoping review (Shekhawat 2013). Language
was not a barrier to inclusion and a number of German articles
were translated in house for inclusion assessment. Author roles in
the review process were pre-defined in the protocol; three authors
independently selected studies for inclusion and two authors ex-
tracted data and judged risk of bias. Risk of publication bias was
not formally assessed as only one study met the criteria for in-
clusion. To be included in the review, studies had to report the
primary outcome measure using a self reported questionnaire. A
number of studies were excluded, therefore, which measured some
secondary outcomes of interest but not this primary outcome.
This may have resulted in some bias in the reviewing of secondary
outcomes.
Agreements and disagreements with other
studies or reviews
This is the first systematic review to examine exclusively the effects
of amplification with hearing aids on tinnitus. However, stud-
ies involving hearing aids have appeared in previous systematic
reviews. The Cochrane review of masking (Hobson 2010) cites
one comparable study from Hazell 1985 where the use of hearing
aids or sound generators within tinnitus retraining therapy was
compared. This clinical study was excluded from this review as it
did not involve the use of a tinnitus questionnaire. Rather, they
used a self devised ’masker-effectiveness questionnaire’. As was
found here, Hazell 1985 reported no difference in the therapeu-
tic effect of using hearing aids or sound generators. Hoare 2011
reviewed Stephens 1985 (a randomised sub-study within Hazell
1985) which also did not report using a questionnaire of tinnitus
severity and so was excluded from the current review. Stephens
1985 reported no significant difference between groups in what
they termed ’psychological’ measures of tinnitus. Our conclusion
that hearing aids and sound generators are equally effective for
tinnitus in a population with some hearing loss is therefore con-
sistent with the conclusions of this earlier work.
Evidence for the effects of hearing aids compared to the option
of not using one is limited to cohort studies and surveys (see
Shekhawat 2013 for a scoping review) and has not been addressed
in any previous systematic review.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Hearing aids are one of a number of therapeutic options offered
to tinnitus patients. However, there is currently no evidence to
support or refute the provision of hearing aids as a primary inter-
vention in themanagement of tinnitus in patients with co-existing
hearing loss. Provision of hearing aids for tinnitus will always have
the potential consequence of reducing the distress associated with
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hearing loss and so any clinical improvement that is specific to tin-
nitus will always be difficult to estimate accurately. We identified
evidence of limited quality that for patients with a particular audi-
ological profile hearing aids seem to be as beneficial as sound gen-
erators. They may in some cases be a better option on the grounds
that amplification may for some patients be more acceptable and
useful than the broadband or patterned sound stimuli delivered
by sound generators (Hoare 2013).
Implications for research
Future research should aspire to produce high-quality evidence
from well-conducted RCTs which report findings to recognised
standards, such as the CONSORT statement (Schulz 2010). The
choice of outcomes measured in trials also needs to be carefully
considered. A recent proposal for international standards for tin-
nitus trials (Landgrebe 2012) considers a comprehensive outcome
assessment of tinnitus to include psychoacoustic measures or rat-
ings of loudness and annoyance as well as questionnaires measur-
ing tinnitus impact. We recommend the use of the Tinnitus Func-
tional Index (TFI) as a core outcome measure (Meikle 2012) as it
was developed to be sensitive to treatment-related changes, unlike
many tinnitus questionnaires currently in use. The TFI also sets a
benchmark of what constitutes a clinically significant benefit, that
is a reduction of 13 points on this 0 to 100 scale. Psychoacous-
tic outcome measures are also important. A case in point is seen
in one of the studies excluded from this review (Schaette 2010).
The conclusions in this study relate to a grouping of participants
according to psychoacoustic estimates of tinnitus pitch made at
baseline. Pitch was not re-evaluated at follow-up so their conclu-
sion hinged on the assumption that it was stable throughout the
study. As far as is feasible, future studies should routinely include
psychoacoustic measures of tinnitus at study endpoints.
The single study included in this review makes one comparison
(hearing aids or sound generators) for a pre-defined subset of pa-
tients (those with hearing loss at higher frequencies) and finds no
between-group difference in outcome. It remains open to future
studies to determine whether, for given populations of help-seek-
ing tinnitus patients, the provision of a hearing aid is superior to
an education-only intervention, no intervention (waiting list con-
trol) or to a hearing aid placebo (where a hearing aid gain is set to
overcome the effects of any occlusion due to the device fitting only,
with zero amplification above the normal threshold). In terms of
efficacy, an important question is whether or not patients with
only mild hearing loss or high-frequency hearing loss should rou-
tinely be offered a hearing aid. Parazzini 2011, however, compared
hearing aid and sound generator use in patients who might rea-
sonably be managed with either device, i.e. patients with tinnitus,
normal hearing at lower frequencies (< 25 dB HL at 2 kHz) and
some hearing loss at higher frequencies. This patient group may
or may not report hearing difficulties as a primary complaint. The
effects of amplification on this patient population lends itself to a
placebo-controlled RCT in a way that would be less appropriate
to patient populations who have severe co-morbid hearing loss.
Future trials should also consider, whilst controlling for hearing
loss, randomising hearing aid features that maximise hearing ben-
efit, such as noise reduction settings, environmental steering, com-
pression andwide dynamic range, to provide evidence about which
features contribute to or reduce the tinnitus benefit a patient may
experience.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Parazzini 2011
Methods Allocation: randomised
Design: a 2-centre, controlled (parallel), repeated-measures trial
Participants Number: 91 participants (49 intervention, 42 control)
Age: mean age = 38.8 (± 1.9) years
Gender: 40 women and 51 men
Setting: patients were evaluated and treated within 2 tinnitus clinics in Milan and
Baltimore
Eligibility criteria:
i) aged 18 to 75 years
ii) tinnitus duration at least 6 months
iii) borderline between category 1 and 2 (according to the Jastreboff classification, with
hearing loss ≤ 25 dB at 2 kHz and HL ≥ 25 dB at frequencies above 2 kHz
iv) bilateral symmetrical hearing loss (difference < 15 dB)
Exclusion criteria: tinnitus arising from external ear disease, middle ear disease or
Ménière’s disease
Baseline characteristics: at initial appointment, mean score on Tinnitus Handicap
Inventory = 58, tinnitus loudness = 7, effect on life = 6.6, tinnitus annoyance = 7.1,
percentage of time when participants were annoyed = 47.0, percentage of time when
participants were aware = 70.1
Interventions Intervention: tinnitus retraining therapy with hearing aid(s)
Control: tinnitus retraining therapy with sound generator(s)
Outcomes Tinnitus Handicap Inventory (THI range 0 to 100)
Tinnitus loudness (VAS range 0 to 10)
Effect on life (VAS range 0 to 10)
Tinnitus annoyance (VAS range 0 to 10)
Percentage of time when participants were annoyed (VAS range 0 to 100)
Percentage of time when participants were aware (VAS range 0 to 100)
Notes Outcomes were measured at the 3, 6 and 12-month follow-up appointments
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization was obtained on the basis
of a random table.” (Parazzini 2011 p549)
Allocation concealment (selection bias) Unclear risk Not reported
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Parazzini 2011 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No blinding, but unclear about the conse-
quent risk of bias
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk None apparent
Selective reporting (reporting bias) Unclear risk Some participants’ data were excluded due
to missing records. “A sample of 101 sub-
jects passed the screening criteria and was
tested across centers.However, due tomiss-
ing recordings in some subjects, the final
pooled data set consisted of 91 subjects…”
(Parazzini 2011 p552)
Tinnitus annoyance, percentage of time
when participants were annoyed and per-
centage of time when participants were
aware of tinnitus were analysed for 51 par-
ticipants only (29 with hearing aids and 22
with sound generators). “These variables
were recorded only from a subset of all the
subjects involved in the study....” (Parazzini
2011 p552)
Other bias Low risk None apparent
THI: Tinnitus Handicap Inventory
VAS: visual analogue scale
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
dos Santos Ferrari 2007 ALLOCATION
Randomised controlled trial
PARTICIPANTS
Adults with tinnitus and hearing loss
INTERVENTIONS
Behind-the-ear hearing aids with open moulds versus behind-the-ear hearing aids with pressure-
vented ear moulds
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(Continued)
Eysel-Gosepath 2004 ALLOCATION
Randomised controlled trial
PARTICIPANTS
Adults with tinnitus and hearing loss
INTERVENTIONS
Hearing aids or sound generators using music and environmental sounds as distraction versus no
device using ’light and warmth’ as distraction, both with counselling and relaxation training
Forti 2010 ALLOCATION
Non-randomised controlled trial
PARTICIPANTS
Adults with tinnitus and hearing loss
INTERVENTION
Open ear canal hearing aids versus ’classical’ hearing aids, no control for amplification
Hazell 1985 ALLOCATION
Non-randomised controlled trial
PARTICIPANTS
Adults with tinnitus and hearing loss
INTERVENTION
Hearing aids versus combination devices versus sound generators
OUTCOME MEASURE
No questionnaire measure of tinnitus severity or handicap, used Crown-Crisp Experiential Index,
’masker effectiveness questionnaire’, 7 ’semantic differential questions’, minimum masking level and
tinnitus loudness
Henry 2006 ALLOCATION
Non-randomised controlled trial
PARTICIPANTS
Adults with tinnitus and hearing loss
INTERVENTION
Hearing aids were an optional component of both intervention and control groups
Kießling 1980 ALLOCATION
Non-randomised controlled trial
PARTICIPANTS
Adults with tinnitus and hearing loss
INTERVENTION
Hearing aids versus sound generators
OUTCOME MEASURE
No appropriate questionnaire measure of tinnitus severity or handicap, used tinnitus loudness,
tinnitus pitch and self reported benefit
Mehlum 1984 ALLOCATION
Randomised controlled trial
PARTICIPANTS
Adults with tinnitus and hearing loss
INTERVENTION
Open ear mould hearing aid versus open ear mould combination device versus sound generator versus no
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(Continued)
intervention
OUTCOME MEASURE
No questionnaire measure of tinnitus severity or handicap; used patient preference as primary out-
come
Melin 1987 ALLOCATION
Randomised controlled trial
PARTICIPANTS
Adults with tinnitus and hearing loss
INTERVENTION
Hearing aids versus no intervention (waiting list)
OUTCOME MEASURE
No appropriate questionnaire measure of tinnitus severity or handicap; used visual analogue scale
(VAS) of tinnitus severity
Moffat 2009 ALLOCATION
Non-randomised controlled trial
PARTICIPANTS
Adults with tinnitus and hearing loss
INTERVENTION
Hearing aids with low-to-medium amplification versus hearing aids with high bandwidth amplification
versus no intervention
OUTCOME MEASURE
No appropriate questionnaire measure of tinnitus severity or handicap; used tinnitus loudness,
tinnitus frequency
Oz 2013 ALLOCATION
Randomised controlled trial
PARTICIPANTS
Adults with tinnitus and hearing loss
INTERVENTION
Combination hearing aids or sound generators with betahistine versus betahistine alone, but data
combined in the report
Schaette 2010 ALLOCATION
Non-randomised, participants allocated according to degree of hearing level
PARTICIPANTS
Adults with tinnitus
INTERVENTION
Comparisonwas not an alternative intervention; comparisonwasmade between groups of individuals
with tinnitus pitch within or outside the range of amplification or output of sound devices
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Characteristics of ongoing studies [ordered by study ID]
NCT01857661
Trial name or title ’The influence of the sound generator combined with conventional amplification for tinnitus control: blind
randomized clinical trial’
Methods Randomised controlled trial, single-blind design
Participants Adults with tinnitus and hearing loss
Interventions Hearing aids versus combination hearing aids
Outcomes Tinnitus Handicap Inventory and psychoacoustic measurements
Starting date September 2012
Contact information Prof Dr Ricardo F. Bento, Otorhinolaryngology Department, Medicine School University of Sao Paulo, Brazil
(rbento@gmail.com)
Notes ClinicalTrials.gov identifier: NCT01857661
Grant number: 11/03001-2
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D A T A A N D A N A L Y S E S
Comparison 1. Hearing aid versus sound generator
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Tinnitus severity, as measured
by change in tinnitus
questionnaire score
1 91 Mean Difference (IV, Fixed, 95% CI) -0.90 [-7.92, 6.12]
2 Tinnitus sound quality, loudness
measured using change in
visual analogue scale
1 91 Mean Difference (IV, Fixed, 95% CI) 0.0 [-0.64, 0.64]
Analysis 1.1. Comparison 1 Hearing aid versus sound generator, Outcome 1 Tinnitus severity, as measured
by change in tinnitus questionnaire score.
Review: Amplification with hearing aids for patients with tinnitus and co-existing hearing loss
Comparison: 1 Hearing aid versus sound generator
Outcome: 1 Tinnitus severity, as measured by change in tinnitus questionnaire score
Study or subgroup Hearing aid Sound generator
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Parazzini 2011 (1) 49 -30.1 (18.36) 42 -29.2 (15.8) 100.0 % -0.90 [ -7.92, 6.12 ]
Total (95% CI) 49 42 100.0 % -0.90 [ -7.92, 6.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.25 (P = 0.80)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours hearing aid Favours sound generator
(1) Higher score means more severe. Scores reduced from ˜58.9 (baseline) to ˜28.8 in the hearing aid group, and from ˜56.8 to ˜27.6 to the sound generator group. Data
estimated from graph.
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Analysis 1.2. Comparison 1 Hearing aid versus sound generator, Outcome 2 Tinnitus sound quality,
loudness measured using change in visual analogue scale.
Review: Amplification with hearing aids for patients with tinnitus and co-existing hearing loss
Comparison: 1 Hearing aid versus sound generator
Outcome: 2 Tinnitus sound quality, loudness measured using change in visual analogue scale
Study or subgroup Hearing aid Sound generator
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Parazzini 2011 (1) 49 -3.4 (1.6) 42 -3.4 (1.5) 100.0 % 0.0 [ -0.64, 0.64 ]
Total (95% CI) 49 42 100.0 % 0.0 [ -0.64, 0.64 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours hearing aid Favours sound generator
(1) Higher score means louder. Data estimated from graphs.
A D D I T I O N A L T A B L E S
Table 1. Tinnitus questionnaires
Questionnaire (author) Range, number of items, sub-
scales
Psychometric properties Clinically significant change
score
Tinnitus Handicap Inventory (
Newman 1996)
0 to 100, 25 items, 3 subscales a = 0.93 for total scale 20 points
Tinnitus Functional Index (
Meikle 2012)
0 to 100, 25 items, 8 subscales a = 0.97 for total scale 13 points
Tinnitus Handicap Question-
naire (Kuk 1990)
0 to 100, 27 items, 3 subscales a = 0.93 for total scale Not known
Tinnitus Questionnaire
(Goebel 1994; Hallam 1996)
0 to 84, 52 items, 5 subscales a = 0.91 for total scale; for sub-
scales a = 0.76 to a = 0.94
5 points
Tinnitus Reaction Question-
naire (Wilson 1991)
0 to 104, 26 items, 4 subscales a = 0.96 and a test-retest corre-
lation of r = 0.88
Not known
Tinnitus Severity Index (Meikle
1995)
12 to 56, 12 items, no subscales Not reported Not known
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A P P E N D I C E S
Appendix 1. Search strategy
CENTRAL PubMed EMBASE (Ovid) CINAHL (EBSCO)
#1 MeSH descriptor Tinnitus
explode all trees
#2 tinnit*
#3 #1 OR #2
#4 MeSH descriptor Hearing
Aids explode all trees
#5 MeSH descriptor Prosthesis
Fitting explode all trees
#6 “hearing aid*”
#7 “ear mold*” OR earmold*
#8 “earmould*”ORearmould*
#9 amplification
#10 #4 OR #5 OR #6 OR #7
OR #8 OR #9
#11 #3 AND #10
#1 Search “Tinnitus”[Mesh]
#2 Search tinnit*
#3 Search #1 OR #2
#4 Search “Hearing
Aids”[Mesh]
#5 Search “Prosthesis
Fitting”[Mesh]
#6 Search “hearing aid*”
#7 Search “ear mold*” OR ear-
mold*
#8 Search “ear mould*” OR
earmould*
#9 Search amplification
#10 Search #4 OR #5 OR #6
OR #7 OR #8 OR #9
#11 Search #3 AND #10
1 exp tinnitus/
2 “tinnit*”.tw.
3 1 or 2
4 exp hearing aid/
5 exp prosthesis/
6 “hearing aid* ”.tw.
7 (“ear mold*” or earmold*).tw.
8 (“ear mould*” or earmould*)
.tw.
9 amplification.tw.
10 4 or 5 or 6 or 7 or 8 or 9
11 3 and 10
S1 (MH “Tinnitus”)
S2 TX tinnit*
S3 S1 or S2
S4 (MH “Hearing Aids+”)
S5 (MH “Prosthetic Fitting”)
S6 TX “hearing aid*”
S7 TX “ear mold*” OR ear-
mold*
S8 TX “ear mould*” OR ear-
mould*
S9 TX amplification
S10 S4 or S5 or S6 or S7 or S8
or S9
S11 S3 and S10
CAB Abstracts (Ovid) Web of Science AMED (Ovid) ISRCTN (mRCT)
1 tinnit*.tw.
2 “hearing aid*”.tw.
3 (“ear mold*” or earmold*).tw.
4 (“ear mould*” or earmould*)
.tw.
5 amplification.tw.
6 2 or 3 or 4 or 5
7 1 and 6
#1 TS=tinnit*
#2 TS=“hearing aid*”
#3 TS=(“ear mold*” or ear-
mold*)
#4 TS=(“ear mould*” or ear-
mould*)
#5 TS=amplification
#6 #2 OR #3 OR #4 OR #5
#7 #6 AND #1
1 exp Tinnitus/
2 tinnit*.tw.
3 1 or 2
4 exp Hearing aids/
5 exp Prosthesis/
6 “hearing aid*”.tw.
7 (“ear mold*” or earmold*).tw.
8 (“ear mould*” or earmould*)
.tw.
9 amplification.tw.
10 4 or 5 or 6 or 7 or 8 or 9
11 3 and 10
Tinnitus AND (amplification
OR “hearing aid” OR “hearing
aids”)
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draft review.
Sereda M: extracted data, assessed risk of bias, provided critical comment on the draft review.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
In the protocol for this review we anticipated including both randomised and non-randomised studies; in the review we further clarified
our definition of ’non-randomised studies’ as set out in Types of studies.
Primary outcomemeasure: we have specified that tinnitus severity or handicapmust bemeasuredusing one of the validated questionnaires
listed in Table 1. We will update this list on an ongoing basis as other questionnaires are validated.
Secondary outcome measures: we have clarified adverse effects as being those associated with both hearing aid fitting ’and use’.
We have provided more detail of our methods for the following: selection of studies; choosing measures of effect for dichotomous
(risk ratio) and continuous data (mean difference or standardised mean difference); handling potential unit of analysis issues (cluster-
randomised trials and multiple observations for the same outcome) and assessment of clinical heterogeneity.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Hearing Aids; Hearing Loss [complications; ∗rehabilitation]; Loudness Perception [∗physiology]; Perceptual Masking [physiology];
Randomized Controlled Trials as Topic; Tinnitus [complications; physiopathology; psychology; ∗therapy]
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MeSH check words
Adult; Humans
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